Aggressive
Showing 1 - 25 of 4,625
A Research Registry on Aggressive PitNETs
Recruiting
- Endocrine Tumor
-
Lyon, FranceHospices Civils de Lyon - Groupement Hospitalier Est
Aug 4, 2023
Passive-Aggressive Personality Disorder Trial in Sevilla (Use of biofeedback and virtual reality in the treatment of aggressive
Recruiting
- Passive-Aggressive Personality Disorder
- Use of biofeedback and virtual reality in the treatment of aggressive outbursts
-
Sevilla, SpainUniversidad de Sevilla
Feb 17, 2023
Aggressive NK Cell Leukemia Trial in Hiroshima (PPMX-T003)
Recruiting
- Aggressive NK Cell Leukemia
-
Hiroshima, JapanHiroshima University Hospital
May 9, 2023
Aggressive Periodontitis Trial (antimicrobial photodynamic therapy, systemic antibiotics)
Completed
- Aggressive Periodontitis
- antimicrobial photodynamic therapy
- systemic antibiotics
- (no location specified)
Dec 8, 2022
Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive
Active, not recruiting
- Aggressive B-Cell Non-Hodgkin Lymphoma
- fractionated first dose rituximab
-
Geneva, SwitzerlandUniversity Hospital Geneva
Apr 21, 2023
Role of the Tumor Microenvironment in Aggressive Meningiomas
Not yet recruiting
- Meningioma
- Surgical waste and Data collect
- (no location specified)
Apr 7, 2023
Arthoplasty Trial in Rohtak (minimal gap arthoplasty v/s aggressive gap arthoplasty)
Recruiting
- Arthoplasty
- minimal gap arthoplasty v/s aggressive gap arthoplasty
-
Rohtak, Haryana, IndiaPgids
Nov 8, 2022
Coronary Artery Disease Progression Trial in Amsterdam
Recruiting
- Coronary Artery Disease Progression
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location AMC
Mar 23, 2023
Cancer Trial in Los Angeles (Cardiac Aggressive Risk MitigAtion Plan)
Recruiting
- Cancer
- Cardiac Aggressive Risk MitigAtion Plan
-
Los Angeles, CaliforniaCancer Clinical Trials Office
Jan 10, 2023
Desmoid Tumors, Aggressive Fibromatosis Trial run by the NCI (PF-03084014)
Active, not recruiting
- Desmoid Tumors
- Aggressive Fibromatosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 14, 2022
Diabetic Kidney Disease Trial in Herlev (ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide,
Recruiting
- Diabetic Kidney Disease
- ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib
-
Herlev, DenmarkDepartment of Nephrology, Herlev and Gentofte Hospital
May 31, 2023
Pancreatitis, Chronic, Pancreatic Duct Stone Trial (Lactated ringers solution, normal saline)
Not yet recruiting
- Pancreatitis, Chronic
- Pancreatic Duct Stone
- Lactated ringers solution
- normal saline
- (no location specified)
Mar 15, 2023
Analyzing Composition of Tears and Blood for Discovery of Novel
Active, not recruiting
- Prostate Cancer
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Jan 6, 2023
Relapsed/Refractory Aggressive B-Cell Malignancies Trial (ONCT-808, Bridging Therapy)
Not yet recruiting
- Relapsed/Refractory Aggressive B-Cell Malignancies
- ONCT-808
- Bridging Therapy
- (no location specified)
Jan 19, 2023
Prostate Cancer Trial in Houston (ADI-PEG 20, Cabazitaxel, Carboplatin)
Not yet recruiting
- Prostate Cancer
- ADI-PEG 20
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Oct 16, 2023
Aggressive Prostate Cancer in Real Life: Initiation, Schedule
Completed
- Prostate Cancer
-
Paris, FranceIpsen Central Contact
Dec 20, 2022
B Cell Lymphoma, Aggressive Lymphoma, Diffuse Large B Cell Lymphoma Trial in Saint Louis (Mosunetuzumab)
Recruiting
- B Cell Lymphoma
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 3, 2023
Aggression, Conduct Disorder Trial in Mannheim (Real-time fMRI feedback, Treatment as usual)
Completed
- Aggression
- Conduct Disorder
- Real-time fMRI feedback
- Treatment as usual
-
Mannheim, GermanyDepartment of Child and Adolescent Psychiatry and Psychotherapy,
Feb 1, 2023
T Cell Lymphoma Trial in New Haven (Mogamulizumab, DA-EPOCH Protocol)
Not yet recruiting
- T Cell Lymphoma
- Mogamulizumab
- DA-EPOCH Protocol
-
New Haven, ConnecticutYale Smilow Cancer Hospital
Aug 14, 2023
Prostate Cancer Metastatic Trial (Pembrolizumab, Carboplatin, Cabazitaxel)
Not yet recruiting
- Prostate Cancer Metastatic
- Pembrolizumab
- +2 more
- (no location specified)
Sep 29, 2022
Retina Disease, Retinopathy of Prematurity, Ranibizumab Trial in Zagazig (Ranibizumab (0.25 mg/0.025 mL))
Completed
- Retina Disease
- +2 more
- Ranibizumab (0.25 mg/0.025 mL)
-
Zagazig, EgyptZagazig University, Faculty of medicine
Jan 26, 2023
Cancer Trial in Milwaukee (Targeted agent, Standard of care agent)
Not yet recruiting
- Cancer
- Targeted agent
- Standard of care agent
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Jan 8, 2023
Cardiovascular Events Among Adults Relapsed or Refractory
Recruiting
- Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma
- +9 more
- Electronic Health Record Review
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Cryoablation for Advanced and Refractory Desmoid Tumors
Recruiting
- Desmoid Tumors
-
Strasbourg, FranceService d'Imagerie Interventionnelle - CHU de Strasbourg - Franc
Oct 30, 2023
Il-17 and Il-18 in Aggressive Periodontitis
Completed
- Aggressive Periodontitis
- non surgical periodontal therapy
-
Cairo, EgyptFaculty of oral and dental medicine,FUE, Cairo,Egypt
Mar 30, 2022